MiRXES developed an ID3EAL reverse transcription quantitative polymerase chain reaction platform for detection of microRNAs and other non-coding RNAs. This technology is the foundation on which their multicancer early detection clinical pipeline is built which includes liver and pancreatic cancer detection. Owlstone Medical, UK Developer of a disease breathalyzer tests for liver disease and hepatocellular carcinoma amongst other diseases. PinPoint, UK The company's platform uses machine learning to combine information from multiple cancer biomarkers and patient information to help identify patients who have a high probability of cancer diagnosis. SeekIn Medical, China